1 Thong BY, "Update on the management of antibiotic allergy" 2 : 77-86, 2010
2 Wolf G, "Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin" 74 : 289-293, 1995
3 Dicpinigaitis PV., "Short- and long-term reproducibility of capsaicin cough challenge testing" 16 : 61-65, 2003
4 Didier A, "Neurogenic inflammation, vascular permeability, and mast cells. Capsaicin desensitization fails to influence IgE-anti-DNP induced vascular permeability in rat airways" 141 : 398-406, 1990
5 Barnes PJ, "Neurogenic inflammation and asthma" 29 : 165-180, 1992
6 Kim D, "Neural aspects of allergic rhinitis" 15 : 268-273, 2007
7 Roche N, "Nasal response to capsaicin in patients with allergic rhinitis and in healthy volunteers: effect of colchicine" 151 : 1151-1158, 1995
8 Philip G, "Inflammatory cellular influx follows capsaicin nasal challenge" 153 : 1222-1229, 1996
9 Sachs B, "Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use" 29 : 1087-1100, 2006
10 Siracusa A, "Epidemiology of occupational rhinitis: prevalence, aetiology and determinants" 30 : 1519-1534, 2000
1 Thong BY, "Update on the management of antibiotic allergy" 2 : 77-86, 2010
2 Wolf G, "Treatment of nonspecific hyper-reflectory rhinopathy (vasomotor rhinitis) with capsaicin" 74 : 289-293, 1995
3 Dicpinigaitis PV., "Short- and long-term reproducibility of capsaicin cough challenge testing" 16 : 61-65, 2003
4 Didier A, "Neurogenic inflammation, vascular permeability, and mast cells. Capsaicin desensitization fails to influence IgE-anti-DNP induced vascular permeability in rat airways" 141 : 398-406, 1990
5 Barnes PJ, "Neurogenic inflammation and asthma" 29 : 165-180, 1992
6 Kim D, "Neural aspects of allergic rhinitis" 15 : 268-273, 2007
7 Roche N, "Nasal response to capsaicin in patients with allergic rhinitis and in healthy volunteers: effect of colchicine" 151 : 1151-1158, 1995
8 Philip G, "Inflammatory cellular influx follows capsaicin nasal challenge" 153 : 1222-1229, 1996
9 Sachs B, "Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use" 29 : 1087-1100, 2006
10 Siracusa A, "Epidemiology of occupational rhinitis: prevalence, aetiology and determinants" 30 : 1519-1534, 2000
11 Bascom R, "Effect of intranasal capsaicin on symptoms and mediator release" 259 : 1323-1327, 1991
12 Moscato G, "EAACI position paper on occupational rhinitis" 10 : 16-, 2009
13 Sanico AM, "Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation" 100 : 632-641, 1997
14 Seitz CS, "Diagnostic testing in suspected fluoroquinolone hypersensitivity" 39 : 1738-1745, 2009
15 Fujimoto S, "Characterization of capsaicin-induced, capsazepine- insensitive relaxation of ileal smooth muscle of rats" 487 : 175-182, 2004
16 Fujimoto S, "Capsaicin-induced, capsazepine-insensitive relaxation of the guinea-pig ileum" 530 : 144-151, 2006
17 Stjärne P, "Capsaicin desensitization of the nasal mucosa reduces symptoms upon allergen challenge in patients with allergic rhinitis" 118 : 235-239, 1998